Literature DB >> 16758503

Radiographic and clinical outcome in early juvenile rheumatoid arthritis and juvenile spondyloarthropathy: a 3-year prospective study.

Anne M Selvaag1, Berit Flatø, Knut Dale, Gunhild Lien, Odd Vinje, Anna Smerdel-Ramoya, Øystein Førre.   

Abstract

OBJECTIVE: To describe radiographic findings at disease onset and 3-year followup in patients with juvenile rheumatoid arthritis (JRA) and juvenile spondyloarthropathy (JSpA), to assess radiographic progression and its predictors, and to prospectively assess clinical outcome and predictors of persistent disease at 3-year followup.
METHODS: A total of 197 patients with JRA/JSpA were examined every 6 months for 3 years. Radiographic examination was performed at baseline and 3-year followup of knees and ankles (all patients) and of other joints on clinical indication. Remission was defined as minimum 6 months without medication and no clinical signs of active disease.
RESULTS: Radiographic abnormalities were found in 88% of the patients at onset and in 81% after 3 years. Frequency of swelling/osteoporosis decreased and frequency of abnormal growth increased from baseline to followup. Knees, hands, and wrists had most frequently radiographic abnormalities. Radiographic progression occurred in 38% of the patients. Joints with swelling/osteoporosis on radiographs, young age, and a large number of mobility-restricted joints at baseline were predictors of radiographic progression. At 3 years, 26% of the patients were in remission and 75% had been treated with disease-modifying antirheumatic drugs. Reduced well-being, a large number of active joints and negative antinuclear antibody at baseline were predictors of persistent disease after 3 years.
CONCLUSION: After 3 years most patients had radiographic abnormalities and persistent disease. Young age, many affected joints, reduced well-being, and negative antinuclear antibody at onset increased the risk of radiographic progression and persistent disease after 3 years.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16758503

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  18 in total

1.  Sleep Fragmentation and Biomarkers in Juvenile Idiopathic Arthritis.

Authors:  Teresa M Ward; Weichao Yuwen; Joachim Voss; Dirk Foell; Faekah Gohar; Sarah Ringold
Journal:  Biol Res Nurs       Date:  2015-10-27       Impact factor: 2.522

2.  Long-term outcomes and disease course of children with juvenile idiopathic arthritis in the ReACCh-Out cohort: a two-centre experience.

Authors:  Amieleena Chhabra; Cal Robinson; Kristin Houghton; David A Cabral; Kimberly Morishita; Lori B Tucker; Ross E Petty; Maggie Larché; Michelle Batthish; Jaime Guzman
Journal:  Rheumatology (Oxford)       Date:  2020-12-01       Impact factor: 7.580

Review 3.  Advances and challenges in imaging in juvenile idiopathic arthritis.

Authors:  Silvia Magni-Manzoni; Clara Malattia; Stefano Lanni; Angelo Ravelli
Journal:  Nat Rev Rheumatol       Date:  2012-03-27       Impact factor: 20.543

Review 4.  2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features.

Authors:  Timothy Beukelman; Nivedita M Patkar; Kenneth G Saag; Sue Tolleson-Rinehart; Randy Q Cron; Esi Morgan DeWitt; Norman T Ilowite; Yukiko Kimura; Ronald M Laxer; Daniel J Lovell; Alberto Martini; C Egla Rabinovich; Nicolino Ruperto
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-04       Impact factor: 4.794

5.  Physical disability, articular, and extra-articular damage in patients with juvenile idiopathic arthritis.

Authors:  Pradip Kumar Sarma; Ramnath Misra; Amita Aggarwal
Journal:  Clin Rheumatol       Date:  2008-05-24       Impact factor: 2.980

Review 6.  Clinical Outcome and Long-term Remission in JIA.

Authors:  Mia Glerup; T Herlin; M Twilt
Journal:  Curr Rheumatol Rep       Date:  2017-11-04       Impact factor: 4.592

7.  Sleep disturbances and behavior problems in children with and without arthritis.

Authors:  Teresa M Ward; Jennifer Sonney; Sarah Ringold; Shellie Stockfish; Carol A Wallace; Carol A Landis
Journal:  J Pediatr Nurs       Date:  2014-03-15       Impact factor: 2.145

8.  Serum levels of osteoprotegerin and receptor activator of nuclear factor -κB ligand in children with early juvenile idiopathic arthritis: a 2-year prospective controlled study.

Authors:  Gunhild Lien; Thor Ueland; Kristin Godang; Anne M Selvaag; Oystein T Førre; Berit Flatø
Journal:  Pediatr Rheumatol Online J       Date:  2010-12-06       Impact factor: 3.054

Review 9.  The clinical effectiveness of intra-articular corticosteroids for arthritis of the lower limb in juvenile idiopathic arthritis: a systematic review.

Authors:  Heidi Jennings; Kym Hennessy; Gordon J Hendry
Journal:  Pediatr Rheumatol Online J       Date:  2014-06-11       Impact factor: 3.054

10.  Amendment of the OMERACT ultrasound definitions of joints' features in healthy children when using the DOPPLER technique.

Authors:  P Collado; D Windschall; J Vojinovic; S Magni-Manzoni; P Balint; G A W Bruyn; C Hernandez-Diaz; J C Nieto; V Ravagnani; N Tzaribachev; A Iagnocco; M A D'Agostino; E Naredo
Journal:  Pediatr Rheumatol Online J       Date:  2018-04-10       Impact factor: 3.054

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.